HES
57
-5
GWW
44
-4
DFS
57
-5
KSS
55
4
MRO
44
-6
LH
52
2
BRK.B
43
7
NWSA
78
-4
THC
65
-3
TEL
71
2
MHK
45
-3
NEE
46
2
RRC
60
-5
RIG
41
-2
EMN
49
-13
COF
53
-4
CTAS
45
3
CRM
64
2
SJM
38
2
NTAP
56
-3
HES
57
-5
GWW
44
-4
DFS
57
-5
KSS
55
4
MRO
44
-6
LH
52
2
BRK.B
43
7
NWSA
78
-4
THC
65
-3
TEL
71
2
MHK
45
-3
NEE
46
2
RRC
60
-5
RIG
41
-2
EMN
49
-13
COF
53
-4
CTAS
45
3
CRM
64
2
SJM
38
2
NTAP
56
-3
Financhill
Back

Ligand Pharmaceuticals Vs. Blueprint Medicines Industry Stock Comparison

Sell
50

LGND
Ligand Pharmaceuticals

Last Price:
84.24
Seasonality Move:
-4%
Sell
46

BPMC
Blueprint Medicines

Last Price:
111.72
Seasonality Move:
10.58%
Sell
50
Ligand Pharmaceuticals (LGND) is a Sell

Is Ligand Pharmaceuticals a Buy, Sell or Hold?

  • The current Ligand Pharmaceuticals [LGND] share price is $84.37. The Score for LGND is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $111.70. The Score for BPMC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LGND Stock Price Chart

What is Ligand Pharmaceuticals's stock price today?

  • The Ligand Pharmaceuticals share price today is $84.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $111.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

LGND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 56.79 Buy
Chaikin Money Flow: 50357 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.49 - 84.25) Buy
Bollinger Bands (100): (72.28 - 83.6) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.81 Buy
Relative Strength Index (14 RSI): 62.72 Buy
Chaikin Money Flow: 288658 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.88 - 108.36) Buy
Bollinger Bands (100): (88.28 - 105.64) Buy

LGND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 82.49 Buy
20-day SMA: 81.27 Buy
50-day SMA: 80.93 Buy
200-day SMA: 70.56 Buy
8-day EMA: 82.96 Buy
20-day EMA: 82.15 Buy
50-day EMA: 80.82 Buy
200-day EMA: 74.94 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 108.39 Buy
20-day SMA: 106.42 Buy
50-day SMA: 104.24 Buy
200-day SMA: 82.56 Buy
8-day EMA: 108.84 Buy
20-day EMA: 106.94 Buy
50-day EMA: 103.3 Buy
200-day EMA: 86.56 Buy

Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.71 per share, and an increase next year of $0.91 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.

Ligand Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):